Stem definition | Drug id | CAS RN |
---|---|---|
prednisone and prednisolone derivatives | 2250 | 630-67-1 |
None
Property | Value | Reference |
---|---|---|
S (Water solubility) | 0.22 mg/mL | Bocci G, Oprea TI, Benet LZ |
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Urinary retention | 69.63 | 51.94 | 22 | 716 | 30279 | 63458005 |
Hepatocellular injury | 63.39 | 51.94 | 20 | 718 | 27361 | 63460923 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Fixed eruption | 41.02 | 39.05 | 9 | 712 | 1691 | 34954519 |
Retinal artery occlusion | 40.10 | 39.05 | 9 | 712 | 1876 | 34954334 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Hepatocellular injury | 68.09 | 35.04 | 28 | 1554 | 47565 | 79695241 |
Cholestasis | 52.68 | 35.04 | 24 | 1558 | 52085 | 79690721 |
Fixed eruption | 51.97 | 35.04 | 12 | 1570 | 2942 | 79739864 |
Urinary retention | 47.72 | 35.04 | 23 | 1559 | 56607 | 79686199 |
Retinal artery occlusion | 45.49 | 35.04 | 11 | 1571 | 3283 | 79739523 |
Hepatic cytolysis | 42.31 | 35.04 | 17 | 1565 | 27134 | 79715672 |
None
Source | Code | Description |
---|---|---|
FDA MoA | N0000175450 | Corticosteroid Hormone Receptor Agonists |
FDA EPC | N0000175576 | Corticosteroid |
MeSH PA | D006728 | Hormones |
MeSH PA | D000893 | Anti-Inflammatory Agents |
MeSH PA | D000970 | Antineoplastic Agents |
MeSH PA | D018931 | Antineoplastic Agents, Hormonal |
MeSH PA | D005938 | Glucocorticoids |
CHEBI has role | CHEBI:35472 | anti-inflammatory drugs |
CHEBI has role | CHEBI:35610 | antineoplastic agents |
CHEBI has role | CHEBI:35703 | Xenobiotic |
CHEBI has role | CHEBI:35705 | immunosuppressive agents |
CHEBI has role | CHEBI:37962 | adrenergic agents |
CHEBI has role | CHEBI:49103 | drug metabolites |
CHEBI has role | CHEBI:78298 | environmental contaminants |
None
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 12.78 | acidic |
pKa2 | 13.36 | acidic |
None
None
None
ID | Source |
---|---|
D08413 | KEGG_DRUG |
3694-41-5 | SECONDARY_CAS_RN |
4017988 | VANDF |
CHEBI:135823 | CHEBI |
CHEBI:8378 | CHEBI |
TUA | PDB_CHEM_ID |
CHEMBL2111103 | ChEMBL_ID |
CHEMBL2107364 | ChEMBL_ID |
181625 | PUBCHEM_CID |
DB00860 | DRUGBANK_ID |
268872 | RXNORM |
5347 | MMSL |
59710 | MMSL |
d00084 | MMSL |
002155 | NDDF |
005522 | NDDF |
116601002 | SNOMEDCT_US |
52388000 | SNOMEDCT_US |
897039000 | SNOMEDCT_US |
C0889299 | UMLSCUI |
C0032950 | UMLSCUI |
535 | INN_ID |
5755 | PUBCHEM_CID |
D011239 | MESH_DESCRIPTOR_UI |
SR3YX73FW2 | UNII |
None